Cisatracurium bei Patienten mit eingeschränkter Nierenfunktion

Soukup, Jens; Czeslick, Elke; Bunk, Sebastian; Clausen, Tobias; Menzel, M.; Radke, J.

doi:10.1007/s001010050612

Der Anaesthesist

1998

DOI: 10.1007/s001010050612

|View full text |Cite

Cisatracurium bei Patienten mit eingeschränkter Nierenfunktion

Jens Soukup

Elke Czeslick²,

Sebastian Bunk³

et al.

Abstract: The result of this clinical study suggest, that cisatracurium is a suitable choice for patients with renal failure. The necessity for an intraoperative neuromuscular monitoring is given by the marked heterogeneity in the recovery parameters in patients with renal failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2001

2020

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 29 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Endotracheal Intubation in the Pharmaceutical-Poisoned Patient: a Narrative Review of the Literature

et al. 2020

View full text Add to dashboard Cite

Introduction Endotracheal intubation (ETI) is an essential component of the supportive care provided to the critically ill patient with pharmaceutical poisoning; however, specific nuances surrounding intubation including techniques and complications in the context of pharmaceutical poisoning have not been well elucidated. Discussion A search of the available literature on ETI in pharmaceutical-poisoned patients was undertaken using Medline, ERIC, Cochrane database, and PsycINFO using the following MeSH and keyword terms: ("toxicology" OR "poisons" OR "drug overdose" OR "poisoning") AND ("intubation, intratracheal" OR "intubation, endotracheal" OR "airway management" OR "respiration, artificial"). A hand-search was also performed when the literature in the above search required additional conceptual clarification, including using the "Similar Articles" feature of PubMed, along with reviewing articles' reference lists that discussed intubation in the context of a poisoning scenario. Articles with any discussion around the ETI process in the context of a pharmaceutical poisoning were then included. Intubation may be performed in patients poisoned with pharmaceuticals in the context of both single and multiple organ dysfunction including central and peripheral nervous system, pulmonary, or cardiovascular toxicity with hemodynamic instability, or localized effects resulting in mechanical airway obstruction. Certain classes of poisonings may require modifications to the standard rapid sequence induction airway management algorithm. Conclusions ETI is a key component of the supportive care provided to the patient poisoned by a pharmaceutical agent. Clinicians should be aware of the spectrum of toxicities that can necessitate intubation, as well as airway management nuances that are specific to various poisoning presentations.

show abstract

Endotracheal Intubation in the Pharmaceutical-Poisoned Patient: a Narrative Review of the Literature

et al. 2020

View full text Add to dashboard Cite

show abstract

Récupération du bloc neuromusculaire après perfusion continue de cisatracurium chez l’insuffisant rénal

Sztark

Cantini

Bourdallé-Badie

et al. 2001

Annales Françaises d'Anesthésie et de Réanimation

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cisatracurium bei Patienten mit eingeschränkter Nierenfunktion

Abstract: The result of this clinical study suggest, that cisatracurium is a suitable choice for patients with renal failure. The necessity for an intraoperative neuromuscular monitoring is given by the marked heterogeneity in the recovery parameters in patients with renal failure.

Cited by 2 publications

References 29 publications

Endotracheal Intubation in the Pharmaceutical-Poisoned Patient: a Narrative Review of the Literature

Endotracheal Intubation in the Pharmaceutical-Poisoned Patient: a Narrative Review of the Literature

Récupération du bloc neuromusculaire après perfusion continue de cisatracurium chez l’insuffisant rénal

Contact Info

Product

Resources

About